Europe Dominated the Particle Therapy Industry

The size of the particle therapy market was USD 797.1 million in 2021, which will reach USD 1,634.4 million by 2030, powering at a rate of 8.3% in the years to come.

To learn more about this report: https://bit.ly/3C2STPY

This is mostly credited to the high acceptance of particle therapy for cancer treatment in addition to the surge in the count of particle therapy centers globally.

Proton therapy had over 90% share, and it will witness a higher rate, of about 8.5%, in the years to come. This is credited to the high acceptance of this therapy for treating numerous cancers, for example brain tumor, and breast cancer.

Products, for instance synchrotrons, cyclotrons, and synchrocyclotrons, had over 80% share, because of the increasing acceptance of cyclotrons in numerous hospitals together with several advantages offered by them for instance low cost.

Also, the rising predisposition in the direction of nuclear scans for diagnosis, and the convenience of tech advanced diagnostic devices also power the growth of the industry.

Moreover, most of the particle therapy facilities, worldwide, focus on the employment of cyclotrons as opposed to synchrotrons, because of their low cost together with small size.

Pediatric cancer had over 25% share, and it will grow the fastest, powering at a rate of around 9%, in the future, because of its high prevalence globally. 

Particle therapy is generally employed in the treatment of pediatric patients because of the high mitosis rate in children, which needs therapy that directly targets the tumor with few lasting side effects. 

It delivers high precision and radiation control with nearly no exposure to normal body cells.

The European particle therapy market had the largest revenue in the recent past, as stated by a market research organization, P&S Intelligence. Moreover, it will register the highest rate, of around 9%, in the years to come, as a result of the rising count of particle therapy facilities providing clinical operations.

North America followed Europe, of about 30%, in 2021, because of the early acceptance of particle therapy treatment together with the occurrence of numerous hospitals and research institutes.

As per the NAPT, out of 170,000 patients, which were treated with proton therapy worldwide, in excess of 70,000 of them were treated in the U.S. alone, in 2021. 

Likewise, at present, there are about 41 proton therapy centers in North America, intensifying the growth of the market.

Furthermore, the recent clearance of numerous proton therapy solutions in the U.S. by federal organizations also powers the growth of the industry.

It is because of increase in the number of particle therapy centers, the demand for particle therapy treatments is growing day by day in the years to come.